XML 52 R34.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE BENEFIT PLANS (Tables)
12 Months Ended
Dec. 31, 2023
Retirement Benefits [Abstract]  
Schedule of Stock Option Activity under the Plans
Stock option activity under the Plans for the year ended December 31, 2023 was as follows:
Number of
Shares
Weighted-
Average
Exercise
Price
Weighted-
Average
Remaining
Contractual
Term
(in Years)
Aggregate
Intrinsic
Value
Balance—December 31, 202218,153,195$6.07 5.41$120,289 
Granted454,62614.72 
Exercised(6,621,448)4.13 
Canceled(821,235)13.41 
Balance—December 31, 202311,165,138$7.03 5.22$142,444 
Options vested9,462,200$5.70 4.74$131,590 
Schedule of Share-based Compensation, Restricted Stock Units Award Activity
RSU activity under the Plans for the year ended December 31, 2023 was as follows:
Number of
Shares
Weighted-Average
Grant Date Fair Value
Aggregate
Intrinsic
Value
Unvested balance—December 31, 202222,773,053$17.75 $269,779 
Granted7,335,24512.41  
Vested(8,449,866)17.73  
Forfeited(3,297,386)19.91  
Unvested balance—December 31, 202318,361,046$15.24 $355,653 
Summary of Weighted Average Assumptions to Record Stock-Based Compensation Expense for Stock Options Granted
A summary of the weighted-average assumptions we utilized to record stock-based compensation expense for stock options granted is as follows:
Year Ended December 31,
202320222021
Fair value of common stock$14.72 $12.80 $29.99 
Risk-free interest rate3.7 %3.1 %1.3 %
Expected term (in years)6.16.16.2
Expected volatility57.3 %57.7 %57.1 %
Dividend yield— %— %— %
The following table summarizes the assumptions used in estimating the fair value of ESPP Rights:
Year Ended December 31,
202320222021
Risk-free interest rate
3.9% - 5.5%
1.4% - 4.6%
0.0% - 0.5%
Expected term (in years)
0.5 - 2.0
0.5 - 2.0
0.5 - 2.0
Expected volatility
39.2% - 61.0%
59.4% - 76.5%
48.3% - 61.9%
Dividend yield—%—%—%
Summary of Stock-Based Compensation Expense in the Consolidated Statements of Operations
Stock-based compensation expense is classified in the Consolidated Statements of Operations as follows:
Year Ended December 31,
202320222021
Cost of revenue$2,593 $3,089 $2,092 
Research and development49,931 48,779 42,783 
Sales and marketing31,299 30,092 25,992 
General and administrative31,352 28,703 20,316 
Restructuring related charges(5,605)122 — 
Total$109,570 $110,785 $91,183 
Summary of Shares of Common Stock Reserved for Future Issuance
Our common stock reserved for future issuance was as follows:
December 31, 2023December 31, 2022
Stock options outstanding11,165,13818,153,195
RSUs outstanding18,361,04622,773,053
Shares available for future grants16,913,0858,819,998
Total shares of common stock reserved46,439,26949,746,246